The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
119039403 11903940 3 F 20121106 20160711 20160111 20160713 EXP CA-ROCHE-CID000000002221936 ROCHE 64.06 YR M Y 85.00000 KG 20160713 OT CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
119039403 11903940 1 PS RITUXAN RITUXIMAB 1 Intravenous (not otherwise specified) MOST RECENT DOSE ON 04/JUL/2013 B62232,B6227B022,B62502,H06453,H079 103705 1000 MG SOLUTION FOR INFUSION
119039403 11903940 2 SS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) 125276 340 MG SOLUTION FOR INFUSION
119039403 11903940 3 SS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) 125276 640 MG SOLUTION FOR INFUSION
119039403 11903940 4 C METHOTREXATE. METHOTREXATE 1 0
119039403 11903940 5 C ARAVA LEFLUNOMIDE 1 0
119039403 11903940 6 C PLAQUENIL HYDROXYCHLOROQUINE SULFATE 1 0
119039403 11903940 7 C CELEBREX CELECOXIB 1 0
119039403 11903940 8 C FOLIC ACID. FOLIC ACID 1 0
119039403 11903940 9 C AMITRIPTYLINE AMITRIPTYLINE 1 0
119039403 11903940 10 C RALIVIA TRAMADOL HYDROCHLORIDE 1 0
119039403 11903940 11 C NEXIUM ESOMEPRAZOLE MAGNESIUM 1 0
119039403 11903940 12 C ASA ASPIRIN 1 0
119039403 11903940 13 C AVAPRO IRBESARTAN 1 0
119039403 11903940 14 C DIPHENHYDRAMINE HCL DIPHENHYDRAMINE HYDROCHLORIDE 1 Oral 0 50 MG
119039403 11903940 15 C ACETAMINOPHEN. ACETAMINOPHEN 1 Oral 0 650 MG
119039403 11903940 16 C METHYLPREDNISOLONE. METHYLPREDNISOLONE 1 Intravenous (not otherwise specified) 0 100 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
119039403 11903940 1 Rheumatoid arthritis
119039403 11903940 2 Rheumatoid arthritis
119039403 11903940 14 Premedication
119039403 11903940 15 Premedication
119039403 11903940 16 Premedication

Outcome of event

Event ID CASEID OUTC COD
119039403 11903940 OT
119039403 11903940 HO
119039403 11903940 LT

Reactions reported

Event ID CASEID DRUG REC ACT PT
119039403 11903940 Acne
119039403 11903940 Arthralgia
119039403 11903940 Blood pressure increased
119039403 11903940 Heart rate increased
119039403 11903940 Hypotension
119039403 11903940 Lung disorder
119039403 11903940 Myocardial infarction
119039403 11903940 Oxygen saturation decreased
119039403 11903940 Painful respiration
119039403 11903940 Pulmonary mass
119039403 11903940 Rheumatoid arthritis
119039403 11903940 Sinusitis
119039403 11903940 Vertebral column mass

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
119039403 11903940 1 20120430 0
119039403 11903940 2 20110118 20120214 0
119039403 11903940 3 20110412 20120214 0
119039403 11903940 14 20120430 0
119039403 11903940 15 20120430 0
119039403 11903940 16 20120430 0